INOVOTION sponsors the World Preclinical Congress Europe !!! If you’re attending WPC Europe, don’t miss out on the opportunity to learn more about INOVOTION’s cutting-edge solution for in vivo studies.
Our founder and CEO, Jean Viallet, PhD, is scheduled to speak in the 3D Cellular Models Session on Thursday, November 16 at 2:35 pm. He will elaborate on how our Unique in vivo Test is a Game-Changer for Evaluating the Efficacy and Toxicity of Anti-Cancer Treatments. You will learn why INOVOTION’s platform is the perfect tool for anticipating preclinical mouse data and reducing the risk level in later phases, which makes it both unique and complementary to other in vivo approaches.